Passive permeability assay of doxorubicin through model cell membranes under cancerous and normal membrane potential conditions
- 1 January 2020
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 146, 133-142
Abstract
No abstract availableKeywords
Funding Information
- KU Leuven
- Fonds Wetenschappelijk Onderzoek
This publication has 36 references indexed in Scilit:
- Tuning the Size and Properties of ClyA Nanopores Assisted by Directed EvolutionJournal of the American Chemical Society, 2013
- Membrane potential and cancer progressionFrontiers in Physiology, 2013
- Drug Resistance in Breast Cancer Cells: Biophysical Characterization of and Doxorubicin Interactions with Membrane LipidsMolecular Pharmaceutics, 2010
- Doxorubicin as a Molecular Nanotheranostic Agent: Effect of Doxorubicin Encapsulation in Micelles or Nanoemulsions on the Ultrasound-Mediated Intracellular Delivery and Nuclear TraffickingMolecular Pharmaceutics, 2010
- Analysis of Single Nucleic Acid Molecules with Protein Nanopores2010
- Mechanisms of Drug Resistance in Cancer ChemotherapyMedical Principles and Practice, 2005
- Molecular Dynamics Study on the Effect of Chain Branching on the Physical Properties of Lipid Bilayers: Structural StabilityThe Journal of Physical Chemistry B, 2003
- High-Throughput Permeability pH Profile and High-Throughput Alkane/Water logPwith Artificial MembranesJournal of Medicinal Chemistry, 2001
- Order–disorder transition in bilayers of diphytanoyl phosphatidylcholineBiochimica et Biophysica Acta (BBA) - Biomembranes, 2000
- Transport Studies of Doxorubicin in Model Membranes Indicate a Difference in Passive Diffusion across and Binding at the Outer and Inner Leaflet of the Plasma MembraneBiochemistry, 1994